Author:
Roth Michael D.,Tseng Chi-Hong,Clements Philip J.,Furst Daniel E.,Tashkin Donald P.,Goldin Jonathan G.,Khanna Dinesh,Kleerup Eric C.,Li Ning,Elashoff David,Elashoff Robert M.,
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Reference29 articles.
1. Changes in causes of death in systemic sclerosis, 1972-2002;Steen;Ann Rheum Dis,2007
2. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma;Hoyles;Arthritis Rheum,2006
3. Cyclophosphamide versus placebo in scleroderma lung disease;Tashkin;N Engl J Med,2006
4. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease;Tashkin;Am J Resp Crit Care Med,2007
5. Cyclophosphamide for scleroderma lung disease;Martinez;N Engl J Med,2006
Cited by
107 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献